Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Allied Market Research

Fill Finish Manufacturing Market - Global Opportunity Analysis and Industry Forecast, 2020–2027

A10492
Pages: NA
Jun 2021 | 35 Views
 
Author(s) : NA
Tables: NA
Charts: NA
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Fill Finish Manufacturing Market

Request Now !

In the pharmaceutical industry, fill and finishis the process of filling vials with vaccine and finishing the process of packaging the medicine for distribution. Many vaccine manufacturers use third parties to fill and finish their vaccines.Fill-finish processing comes after upstream bioprocessing, formation of the active agent by cell culture or fermentation, and downstream purification.This is when the final product has the greatest value, and, thus, the most to lose to a product failure. At these later stages of development, tried-and-true processes tend to be used the most. Innovations can introduce elements of risk, expense, and regulatory work into bioprocess operations. This includes formulation, mixing, or other preparation of active agents into final form, which may include liquid or lyophilized powder, and filling and sealing within final containers, which increasingly include prefilled syringes and other delivery systems.

Fill-Finish-Manufacturing

Market scope and structure analysis:

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2020

Forecast period

2021–2027

Forecast units

Value (USD)

Segments covered

Product, End User, and Region

Regions covered

North America (U.S. and Canada), Europe (Germany, UK, France, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of LATAM) and Middle East and Africa

Companies covered

Major players analyzed includeBecton, Dickson and Company, Syntegon Technology GmbH, I.M.A. (IndustriaMacchineAutomatiche) S.p.A., Stevanato Group, West Pharmaceutical Services, Inc., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger& Co. GmbH, and Gerresheimer AG

 

COVID-19 scenarioanalysis:

Pharmaceutical and biotechnological companies together with governments around the globe are working to combat the COVID-19 outbreak. This is carried out by supporting development of vaccines to schedule for medicines supply chain challenges. Furthermore, there are around 115 vaccine candidates and other 155 molecules that are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have seen huge boost in demand for management of COVID-19. There is an increase in demand for the drug, which has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of the drug. Hence, owing  to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is anticipated to witness a substantial growth in the next few years.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The major factor affecting the industry includes increase technological advancements in the fill-finish manufacturing processes, which are designed such that it meets the market demand. There is a steep growth observed in the biopharmaceutical industry, which would help the industry gain traction in the coming years.Furthermore, surge in adoption of prefilled syringes for parenteral dosage forms would help the industry boost in the next few years.

Surge in number of mergers and acquisitions to propel the market

Increase in number of mergers and acquisitions is anticipated to help the industrygrow in the coming years. For instance, in January 2020, Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for pharmaceutical and biologics industries, announced it has acquired TriPharm Services, a new state-of-the-art sterile fill-finish manufacturing center located near Research Triangle Park, North Carolina. The acquisition of TriPharm follows recently announced $17 million expansion of Alcami's sterile fill-finish facility in Charleston, South Carolina.

In conjunction with this acquisition, funds affiliated with Madison Dearborn Partners, LLC, Alcami's existing majority owner, made an additional equity investment to fund Alcami's growth plan and the former majority owner of TriPharm, Ampersand Capital Partners, rolled a portion of its TriPharm ownership interest into an ownership interest in Alcami.

Key segments covered:

Segments

Subsegments

Product

  • Consumables
  • Prefilled syringes
  • Vials
  • Cartridges
  • Other Consumables
  • Instruments
  • Systems Type
  • Standalone
  • Integrated
  • Machine Type
  • Automated machines
  • Semi-automated & manual machines

End User

  • CMOs
  • Pharmaceutical and Biotechnological Companies
  • Others

 

Key benefits of the report:

  • This study presents the analytical depiction of the global fill finish manufacturing industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global fill finish manufacturing market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global fill finish manufacturing market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in thefill finish manufacturing market.
  • The report provides a detailed global fill finish manufacturing market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the fill finish manufacturingmarket research report:

  • Which are the leading market players active in the fill finish manufacturing market?
  • What would be the detailed impact of COVID-19 on the market?
  • What current trends would influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the fill finish manufacturing market?
  • What are the projections for the future that would help in taking further strategic steps?

Fill Finish Manufacturing Market - Global Opportunity Analysis and Industry Forecast, 2020–2027

In the pharmaceutical industry, fill and finishis the process of filling vials with vaccine and finishing the process of packaging the medicine for distribution. Many vaccine manufacturers use third parties to fill and finish their vaccines.Fill-finish processing comes after upstream bioprocessing, formation of the active agent by cell culture or fermentation, and downstream purification.This is when the final product has the greatest value, and, thus, the most to lose to a product failure. At these later stages of development, tried-and-true processes tend to be used the most. Innovations can introduce elements of risk, expense, and regulatory work into bioprocess operations. This includes formulation, mixing, or other preparation of active agents into final form, which may include liquid or lyophilized powder, and filling and sealing within final containers, which increasingly include prefilled syringes and other delivery systems.

Market scope and structure analysis:

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2020

Forecast period

2021–2027

Forecast units

Value (USD)

Segments covered

Product, End User, and Region

Regions covered

North America (U.S. and Canada), Europe (Germany, UK, France, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of LATAM) and Middle East and Africa

Companies covered

Major players analyzed includeBecton, Dickson and Company, Syntegon Technology GmbH, I.M.A. (IndustriaMacchineAutomatiche) S.p.A., Stevanato Group, West Pharmaceutical Services, Inc., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger& Co. GmbH, and Gerresheimer AG

COVID-19 scenarioanalysis:

Pharmaceutical and biotechnological companies together with governments around the globe are working to combat the COVID-19 outbreak. This is carried out by supporting development of vaccines to schedule for medicines supply chain challenges. Furthermore, there are around 115 vaccine candidates and other 155 molecules that are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have seen huge boost in demand for management of COVID-19. There is an increase in demand for the drug, which has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of the drug. Hence, owing  to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is anticipated to witness a substantial growth in the next few years.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The major factor affecting the industry includes increase technological advancements in the fill-finish manufacturing processes, which are designed such that it meets the market demand. There is a steep growth observed in the biopharmaceutical industry, which would help the industry gain traction in the coming years.Furthermore, surge in adoption of prefilled syringes for parenteral dosage forms would help the industry boost in the next few years.

Surge in number of mergers and acquisitions to propel the market

Increase in number of mergers and acquisitions is anticipated to help the industrygrow in the coming years. For instance, in January 2020, Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for pharmaceutical and biologics industries, announced it has acquired TriPharm Services, a new state-of-the-art sterile fill-finish manufacturing center located near Research Triangle Park, North Carolina. The acquisition of TriPharm follows recently announced $17 million expansion of Alcami's sterile fill-finish facility in Charleston, South Carolina.

In conjunction with this acquisition, funds affiliated with Madison Dearborn Partners, LLC, Alcami's existing majority owner, made an additional equity investment to fund Alcami's growth plan and the former majority owner of TriPharm, Ampersand Capital Partners, rolled a portion of its TriPharm ownership interest into an ownership interest in Alcami.

Key segments covered:

Segments

Subsegments

Product

  • Consumables
  • Prefilled syringes
  • Vials
  • Cartridges
  • Other Consumables
  • Instruments
  • Systems Type
  • Standalone
  • Integrated
  • Machine Type
  • Automated machines
  • Semi-automated & manual machines

End User

  • CMOs
  • Pharmaceutical and Biotechnological Companies
  • Others

 

Key benefits of the report:

  • This study presents the analytical depiction of the global fill finish manufacturing industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global fill finish manufacturing market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global fill finish manufacturing market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in thefill finish manufacturing market.
  • The report provides a detailed global fill finish manufacturing market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the fill finish manufacturingmarket research report:

  • Which are the leading market players active in the fill finish manufacturing market?
  • What would be the detailed impact of COVID-19 on the market?
  • What current trends would influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the fill finish manufacturing market?
  • What are the projections for the future that would help in taking further strategic steps?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 
PURCHASE OPTIONS

Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 
Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Fill Finish Manufacturing Market- Global Opportunity Analysis and Industry Forecast, 2020–2027

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $8,096
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers